Skip to main content
Sign In
 


Kathryn L. Hassell, M.D.

Professor of Medicine

 

Medical School:  University of Minnesota Medical School, Minneapolis, Minnesota

 

Postgraduate training:

1986-1989                   Intern and Resident in Internal Medicine, North Carolina Memorial Hospital, University of North Carolina, Chapel Hill, North Carolina

1989-1992                   Fellow in Hematology/Oncology, University of Colorado School of Medicine, Denver, Colorado

 

 

When arrived at UCD: 1989

 

Past and current professional positions:

1991-2002                   Associate Director, Colorado Sickle Cell Treatment and Research Center, Denver, Colorado

1992-1993                   Instructor in Medicine, Division of Hematology, University of Colorado School of Medicine, Denver, Colorado

1993-1999                   Assistant Professor of Medicine, University of Colorado School of Medicine, Denver, Colorado

1999-2008                   Associate Professor of Medicine, University of Colorado School of Medicine, Denver, Colorado

2002-2003                   Interim Director, Colorado Sickle Cell Treatment and Research Center, Denver, Colorado

2003-Present               Director, Colorado Sickle Cell Treatment and Research Center, Denver, Colorado

2008-Present               Professor of Medicine, University of Colorado School of Medicine, Denver, Colorado

 

 

Memberships and other information:

            Council on Thrombosis

            American Heart Association

            American Society of Hematology

            International Society of Thrombosis & Haemostasis

            American Society of Clinical Pathologists

 

Board Certification:

            Internal Medicine - 1989

            Medical Oncology - 1991, 2001

            Hematology - 1992, 2002

 

 

Awards received:

1986                            Alpha Omega Alpha

 

 

Major Scientific Interest:  Coagulation disorders including antiphospholipid antibody syndrome and heparin-induced thrombocytopenia, investigation of novel anticoagulant therapies and strategies, hemoglobinopathies/sickle cell disease including mechanisms of vascular injury and chronic organ damage

 

Major Clinical Interest:  Coagulation disorders and anticoagulation management, hemoglobinopathies including sickle cell disease, hematology support of the Bloodless Surgery Program

 

 

Representative Publications:

 

  1. K.L. Hassell and R. Marlar.  Acquired protein S deficiency in HIV infected individuals.  Clin Hemostasis Rev 6:14, 1992.
  2. K.L. Hassell, P.A. Lane and J.R. Eckman.  Acute multiorgan failure syndrome:  A potentially catastrophic complication of severe sickle cell pain episodes.  Am J Med 96:155-162, 1994.
  3. G.R. Buchanan, D.W. Luckey, D.L. Wethers, K.L. Hassell, G.M. Woods, Z.R. Rogers, J.L. Lear, J.L. O’Connell and P.A. Lane.  Functional asplenia in hemoglobin SC disease.  Blood 85:2238-2244, 1995.
  4. B.L. Steel, K.L. Hassell, C. Rajagopalan, T. Parsons, T. Braun, and R.A. Marlar.  Unique case of brothers with moderate Factor XI deficiency and one with severe bleeding after surgery.  Clin Appl Thromb Hemostasis 2:14-17, 1996.
  5. KL Hassell.  Hypercoagulable states in deep venous thrombosis.  Primary Care Case Rev 1(2), 1998.
  6. K.L. Hassell.  Altered hemostasis in pulmonary hypertension.  Blood coagul fibrinolysis 9:107-117, 1998.
  7. K.L. Hassell.  Anticoagulation in Heparin-Induced Thrombocytopenia: An Ongoing Challenge. Hospital Physician 36:56-61, 2000
  8. L. Barbour and K Hassell.  Prevention of Deep Vein Thrombosis and Pulmonary Embolism.  ACOG Pract Bull 21, October 2000.